PARIS--(BUSINESS WIRE)--This year, the Fondation IPSEN Endocrine Regulations Prize was presented
at the European Congress of Endocrinology, in Dublin, on May 19th,
2015. The international jury chaired by Professor Iain Robinson (National
Institute for Medical Research, London, UK), awarded the prize to
Professor C. Ronald Kahn for his pioneering work on diabetes. C. Ronald
Kahn directs research at the Joslin Diabetes Center, and teaches at
Harvard Medical School. He is a member of the US National Academy of
Sciences. His work has made it possible to elucidate the mechanisms of
the insulin signal transduction pathway and its alterations in type 2
diabetes. Kahn and his collaborators have shown that the insulin
receptor is a kinase, i.e. an enzyme that can phosphorylate a protein.
Thus the hormone adds a phosphate to a tyrosine and thereby triggers the
cascade of biochemical events that characterises the action of insulin.
C.
Ronald Kahn declared: “The Fondation Ipsen Endocrine Regulations
Prize is a true honor. I am delighted to be counted among the previous
recipients for this prestigious award.”
The Endocrine Regulations Prize
Created in 2002, this Prize
of the Fondation Ipsen has been awarded to the renowned
specialists: Wylie VALE (2002), Robert LEFKOWITZ (2003), Pierre CHAMBON
(2004), Thomas HÖKFELT (2005), Roger CONE (2006), William CROWLEY
(2007), Ronald EVANS (2008), Gilbert VASSART (2009) and Shlomo MELMED
(2010), Paolo SASSONE-CORSI (2011), Jeffrey M. FRIEDMAN (2012) and Bert
O’MALLEY (2013) and Maria I. NEW (2014).
The members of the jury are: Iain ROBINSON (National Institute for Medical Research, London, UK), President, Xavier BERTAGNA (Hôpital Cochin, Paris, France), Felipe CASANUEVA (University of Santiago de Compostela, Santiago de Compostela, Spain), Michael CONN (Texas Tech University Health Sciences Center, El Paso, USA), Ezio GHIGO (Ospedale Molinette, Turin, Italy), Ilpo HUHTANIEMI (Imperial College Faculty of Medicine, London, UK), Gérard KARSENTY (Columbia University Medical Center, New York, USA), Paul KELLY (Faculté de Médecine Necker Enfants Malades, Paris, France), Stafford LIGHTMAN (University of Bristol, Bristol, UK), Günter STALLA (Max Planck Institute of Psychiatry, München, Germany) and Phyllis WISE (University of Illinois, Urbana, USA).
The Fondation Ipsen
Established in 1983 under the aegis of
the Fondation de France, the mission of the Fondation Ipsen is to
contribute to the development and dissemination of scientific knowledge.
The long-standing action of the Fondation Ipsen aims at fostering the
interaction between researchers and clinical practitioners, which is
indispensable due to the extreme specialization of these professions.
The ambition of the Fondation Ipsen is to initiate a reflection about
the major scientific issues of the forthcoming years. It has developed
an important international network of scientific experts who meet
regularly at meetings known as Colloques Médecine et Recherche,
dedicated to six main themes: Alzheimer's disease, neurosciences,
longevity, endocrinology, the vascular system and cancer science.
Moreover the Fondation Ipsen has started since 2007 several meetings in
partnership with the Salk Institute, the Karolinska Institutet, the
Massachusetts General Hospital, the Days of Molecular Medicine Global
Foundation as well as with the science journals Nature, Cell
and Science. The Fondation Ipsen produced several hundred
publications; more than 250 scientists and biomedical researchers have
been awarded prizes and research grants.
www.fondation-ipsen.org
